v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Operating activities      
Net income (loss) $ 90,585 $ (182,285) $ (232,378)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 126,838 77,245 55,908
Amortization of intangible assets 18,416 16,565 12,902
Amortization of deferred contract acquisition costs 238,901 170,808 113,884
Non-cash operating lease cost 13,398 9,440 9,103
Stock-based compensation expense 631,519 526,504 309,952
Deferred income taxes (3,387) 1,306 (13,956)
Realized gains on strategic investments (3,936) 0 0
Accretion of short-term investments purchased at a discount (2,285) 0 0
Non-cash interest expense 3,173 2,813 2,469
Change in fair value of strategic investments 1,459 (1,830) (4,823)
Changes in operating assets and liabilities, net of impact of acquisitions      
Accounts receivable, net (217,699) (258,109) (125,354)
Deferred contract acquisition costs (371,649) (298,716) (234,308)
Prepaid expenses and other assets (102,520) (46,807) (29,535)
Accounts payable (18,898) (15,463) 33,248
Accrued expenses and other liabilities 14,586 58,923 38,483
Accrued payroll and benefits 65,102 65,226 32,681
Operating lease liabilities (14,035) (10,364) (9,900)
Deferred revenue 696,639 825,751 616,408
Net cash provided by operating activities 1,166,207 941,007 574,784
Investing activities      
Purchases of property and equipment (176,529) (235,019) (112,143)
Capitalized internal-use software and website development costs (49,457) (29,095) (20,866)
Purchases of strategic investments (17,177) (21,808) (16,309)
Proceeds from sales of strategic investments 2,000 0 0
Business acquisitions, net of cash acquired (239,030) (18,349) (414,518)
Purchases of intangible assets (11,126) (2,323) (680)
Purchases of short-term investments (195,581) (250,000) 0
Proceeds from maturities and sales of short-term investments 348,281 0 0
Purchases of deferred compensation investments (2,031) (64) 0
Net cash used in investing activities (340,650) (556,658) (564,516)
Financing activities      
Payments of debt issuance costs related to revolving line of credit 0 0 (219)
Payments of debt issuance costs related to Senior Notes 0 0 (1,581)
Repayment of loan payable 0 (1,591) 0
Proceeds from issuance of common stock upon exercise of stock options 8,695 8,655 15,899
Proceeds from issuance of common stock under the employee stock purchase plan 76,375 59,419 50,277
Capital contributions from non-controlling interest holders 8,088 10,954 8,155
Net cash provided by financing activities 93,158 77,437 72,531
Effect of foreign exchange rates on cash, cash equivalents and restricted cash 1,958 (1,495) (4,774)
Net increase in cash, cash equivalents and restricted cash 920,673 460,291 78,025
Cash, cash equivalents and restricted cash at beginning of period 2,456,924 1,996,633 1,918,608
Cash, cash equivalents and restricted cash at end of period 3,377,597 2,456,924 1,996,633
Cash and cash equivalents 3,375,069 2,455,369 1,996,633
Restricted cash included in prepaid expenses and other assets 2,528 1,555 0
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows 3,377,597 2,456,924 1,996,633
Supplemental disclosure of cash flow information:      
Interest paid 22,500 22,551 13,088
Income taxes paid, net of refunds received 22,608 11,943 74,677
Supplemental disclosure of non-cash investing and financing activities:      
Net (decrease) increase in property and equipment included in accounts payable and accrued expenses (3,081) 22,421 6,522
Vesting of early exercised stock options 0 2,204 3,165
Equity consideration for acquisitions 652 50 4,011
Operating lease liabilities arising from obtaining operating right of-use assets 16,445 18,464 4,867
Proceeds from sales of strategic investments not yet received 8,774 0 0
Stock-based compensation included in capitalized software development costs and fixed assets $ 31,919 $ 20,193 $ 10,879